89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

Clinical trial NCT05423197 · WITHDRAWN

Trial details

NCT number: NCT05423197
Sponsor: Andrei Iagaru
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head-and-neck Squamous Cell Carcinoma

Start date: 2026-06-01
Primary completion: 2027-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.